Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Luo Yuling 2. Issuer Name and Ticker or Trading Symbol Alamar Biosciences, Inc. [ALMR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O ALAMAR BIOSCIENCES, INC., 47071 BAYSIDE PARKWAY 3. Date of Earliest Transaction (Month/Day/Year) 04/16/2026 (Street) FREMONT, CA 94538 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class B Common Stock 04/20/2026 C(1) 1,386,746 A (1) 1,499,797 D Class B Common Stock 04/20/2026 C(2) 364,268 A (2) 1,864,065 D Class B Common Stock 04/20/2026 J(3) 1,864,065 D (3) 0 D Common Stock 04/20/2026 J(3) 1,864,065 A (3) 1,864,065 D Common Stock 04/20/2026 A(4) 76,509 A $ 0 1,940,574 D Class B Common Stock 04/20/2026 C(1) 1,224,152 A (1) 1,224,152 I By Spouse Class B Common Stock 04/20/2026 J(3) 1,224,152 D (3) 0 I By Spouse Common Stock 04/20/2026 J(3) 1,224,152 A (3) 1,224,152 I By Spouse

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17	04/16/2026		A		341,191		(5)	04/15/2036	Common Stock	341,191	$ 0	341,191	D
Class A Common Stock	(1)	04/20/2026		C			1,020,742	(1)	(1)	Class B Common Stock	1,020,742	$ 0	0	D
Founders Preferred Stock	(1)	04/20/2026		C			366,004	(1)	(1)	Class B Common Stock	366,004	$ 0	0	D
Series A-1 Preferred Stock	(2)	04/20/2026		C			880,802	(2)	(2)	Class B Common Stock	364,268	$ 0	0	D
Class A Common Stock	(1)	04/20/2026		C			1,224,152	(1)	(1)	Class B Common Stock	1,224,152	$ 0	0	I	By Spouse
Stock Option (Right to Buy)	$2.51	04/20/2026		J(3)			266,311	(6)	02/15/2027	Class B Common Stock	266,311	$ 0	0	D
Stock Option (Right to Buy)	$2.51	04/20/2026		J(3)		266,311		(6)	02/15/2027	Common Stock	266,311	$ 0	266,311	D
Stock Option (Right to Buy)	$2.51	04/20/2026		J(3)			25,310	(6)	02/15/2027	Class B Common Stock	25,310	$ 0	0	D
Stock Option (Right to Buy)	$2.51	04/20/2026		J(3)		25,310		(6)	02/15/2027	Common Stock	25,310	$ 0	25,310	D
Stock Option (Right to Buy)	$1.53	04/20/2026		J(3)			23,986	(7)	01/17/2033	Class B Common Stock	23,986	$ 0	0	D
Stock Option (Right to Buy)	$1.53	04/20/2026		J(3)		23,986		(7)	01/17/2033	Common Stock	23,986	$ 0	23,986	D
Stock Option (Right to Buy)	$1.53	04/20/2026		J(3)			20,023	(6)	04/24/2033	Class B Common Stock	20,023	$ 0	0	D
Stock Option (Right to Buy)	$1.53	04/20/2026		J(3)		20,023		(6)	04/24/2033	Common Stock	20,023	$ 0	20,023	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)			27,700	(8)	04/16/2034	Class B Common Stock	27,700	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)		27,700		(8)	04/16/2034	Common Stock	27,700	$ 0	27,700	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)			1,033,912	(9)	01/15/2035	Class B Common Stock	1,033,912	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)		1,033,912		(9)	01/15/2035	Common Stock	1,033,912	$ 0	1,033,912	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)			37,086	(10)	01/15/2035	Class B Common Stock	37,086	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(3)		37,086		(10)	01/15/2035	Common Stock	37,086	$ 0	37,086	D
Stock Option (Right to Buy)	$7.6	04/20/2026		J(3)			42,334	(11)	01/14/2036	Class B Common Stock	42,334	$ 0	0	D
Stock Option ((Right to Buy)	$7.6	04/20/2026		J(3)		42,334		(11)	01/14/2036	Common Stock	42,334	$ 0	42,334	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Luo Yuling C/O ALAMAR BIOSCIENCES, INC. 47071 BAYSIDE PARKWAY FREMONT, CA 94538	X		Chief Executive Officer

Signatures

/s/ Timothy White, Attorney-in-Fact		04/20/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the "IPO").
(2)	The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO.
(3)	Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
(4)	Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.
(5)	Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
(6)	Fully vested.
(7)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2023, subject to the reporting person's continuous service as of each such vesting date.
(8)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date.
(9)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date.
(10)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
(11)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.